CHARITY SCOTT - College of Law



Georgia State University College of Law85 Park Place NE, Atlanta, GA 30303Tel: (404) 413-9092Email: yheled@gsu.eduEDUCATIONColumbia University School of Law, New York, New YorkJ.S.D., 2011 (Haffernan Fellow)Dissertation title: “Regulation of Novel Biotechnologies”Columbia University School of Law, New York, New York LL.M., 2004 (Harlan Fiske Stone Scholar)Tel Aviv University Faculty of Law, Tel Aviv, IsraelLL.B., 2000Tel Aviv University Faculty of Life Sciences, Tel Aviv, IsraelDiploma in Biology (83 academic credit hours), 2000 (Magna Cum Laude)TEACHING EXPERIENCEApril 2016 – Present Associate Professor of Law (with tenure), College of Law, Georgia State University, Atlanta, GeorgiaFebruary-March 2018Guest Lecturer at University of Warsaw School of Law, Center for American Legal StudiesJune 2011 – April 2016Assistant Professor of Law, College of Law, Georgia State University, Atlanta, GeorgiaAcademic Year 2002-2003Teaching Assistant in Tort Law, The College of Management, Academic Division – School of Law, Rishon Lezion, IsraelSpring 2002Teaching Assistant, Tort Law, Tel Aviv University Faculty of Law, Tel Aviv, IsraelFall 2001, Fall 2002Teaching Assistant, Tort Law, The Interdisciplinary Center in Herzliya, Herzliya, IsraelSpring 2000Teaching Assistant, Professional Responsibility, Tel Aviv University Faculty of Law, Tel Aviv, Israel & The Interdisciplinary Center in Herzliya, Herzliya, IsraelOTHER PROFESSIONAL EXPERIENCESep. 2007 – June 2011Associate, Goodwin Procter LLP, New York, New YorkOct. 2004 – Mar. 2006Legal Researcher, Drug Development Think Tank Project, New York, New YorkMar. 2001 – Feb. 2002Articled Clerk (apprentice attorney), S. Horowitz & Co., Advocates, Tel Aviv, IsraelPUBLICATIONSYaniv Heled and Liza Vertinsky, Genetic Paparazzi: Beyond Genetic Privacy (forthcoming 2020)Yaniv Heled and Liza Vertinsky, Genetic Paparazzi, in Consuming Genetic Technologies: Ethical and Legal Considerations (Cambridge Univ. Press, Forthcoming)The Case for Disclosure of Biologics Manufacturing Information, 47 J. L. Med. & Ethics 54 (2019)Yaniv Heled, Liza Vertinsky, and Cass Brewer, Why Healthcare Companies Should Be(come) Benefit Corporations, 60 B.C.L. Rev. 73 (2019).Follow-On Biologics Are Set Up to Fail, 2018 U. Ill. L. Rev. Online 113 (2018). Biologics, Biosimilars, and Other Idiosyncrasies, in Contemporary Issues in Pharmaceutical Patent Law (Bryan Mercurio & Daria Kim eds., Routledge 2017). Regulatory Competitive Shelters as Incentives for Innovation in Agro-Biotech, 2015 Mich. St. L. Rev. 553 (2015). Regulatory Competitive Shelters in the Area of Personalized Medicine, 21 J. Sci. & Tech. Law 287 (2015). Regulatory Competitive Shelters, 76 Ohio St. L. Rev. 299 (2015). On Patenting Human Organisms or How the Abortion Wars Feed into the Ownership Fallacy, 36 Cardozo L. Rev. 241 (2014). Shine Tu, Christopher Holman, Adam Mossoff, Ted Sichelman, Michael Risch, Jorge L. Conteras, Yaniv Heled, Greg Dolin and Lee Petherbridge, Response to ‘Pervasive Sequence Patents Cover the Entire Human Genome,’ 6 Genome Med. 14 (2014) (peer reviewed). Ryan G. Vacca, Jim Chen, Jay Dratler, Tom Folsom, Timothy Hall, Yaniv Heled, Frank Pasquale, Elizabeth Reilly, Jeff Samuels, Kathy Strandburg, Kara Swanson, Andrew Torrance, Katharine Van Tassel, Intellectual Property and Public Health – A White Paper, 7 Akron Intell. Prop. J. (2013), available at (including a summary of issues discussed at the Sixth Annual Intellectual Property Scholars Forum hosted by the University of Akron School of Law’s Center for Intellectual Property & Technology in October 2012).Statutory Exclusivities vs. Patents in Biological Pharmaceuticals – Do We Really Need Both?, 18 Mich. Telecom. & Tech. L. Rev. 419 (2012).Why Primary Patents Covering Biologics Should Be Unenforceable Against Generic Applicants Under the Biologics Price Competition and Innovation Act, 21 Annals Health L. 211 (2012) (symposium issue; an abridged version of 18 Mich. Telecom. & Tech. L. Rev. 419).The Regulation of Genetic Aspects of Donated Reproductive Tissue – The Need for Federal Regulation, 11 Columbia Sci. & Tech. L. Rev. 243 (2010).On Presidents, Agencies and the Stem Cells Between Them: A Legal Analysis of President Bush’s and the Federal Government’s Policy on the Funding of Research Involving Human Embryonic Stem Cells, 60 Admin. L. Rev. 65 (2008).MEDIA AND BLOGSCheaper Versions of the Most Expensive Drugs may be Coming, but Monopolies will Likely Remain, The Conversation, June 4, 2019, . Biosimilars are a Distraction, Health Affairs Blog, Apr. 8, 2019, . Alter Rules of Liability, Atlanta J.-Const., Oct. 7, 2014, at A12.Patent Trolls as Parasites, JURIST - Forum, Apr. 28, 2014, . Healthcare Reform Creates Pathway for Biosimilar Biologics (with Frederick Rein and Scott Warren), , April 9, 2010, Deny Parents New Technology?, Haaretz (Israeli Daily Newspaper), May 24, 2005, at B2. MANUSCRIPTS IN PREPARATIONA Theory of Genetic InterestsBiologics and the Problem of Triple-Whammy Protection LEGISLATIVE AND EXPERT TESTIMONY SEQ CHAPTER \h \r 1“Autonomous Vehicles Law and Policy,” testimony before the Georgia House of Representatives Committee for the Study of Autonomous Vehicle Technology, September 18, 2014, recording available at . PRESENTATIONS“The Overprotection of Biological Pharmaceuticals,” Pharmaceutical Innovation, Patent Protection, and Regulatory Exclusivities, Texas A&M University School of Law, Fort Worth, Texas, October 2019. “(Why) Follow-On Biologics Are Set Up to Fail and What We Can Do About It,” First Do No Harm: A Patient-Driven Approach to Navigating the Health Law, Intellectual Property, and Technology Maze, Nova Southeastern University Florida Shepard Broad College of Law, Fort Lauderdale, Florida, October 2019. “A Theory of Genetic Interests,” Wiet Life Science Law Scholars Conference, Loyola University Chicago School of Law, Chicago, Illinois, September 2019.“Toward Effective Competition in Biologics,” 42nd Annual Health Law Professors Conference, Loyola University Chicago School of Law, Chicago, Illinois, June 2019. “(Why) Follow-On Biologics Are Set Up to Fail and What We Can Do About It,” Changing Regulation of Pharmaceuticals: Pricing, Intellectual Property, Trade and Ethics, McGeorge School of Law, Sacramento, California, April 2019.“(Why) Follow-On Biologics Are Set Up to Fail,” FDA Past, Present, and Future, American University School of Law, Washington DC, October 2018. “Toward Effective Competition in Biologics,” Wiet Life Science Law Scholars Conference, Loyola University Chicago School of Law, Chicago, Illinois, September 2018.“(Why) Follow-On Biologics Are Set Up to Fail,” 41st Annual Health Law Professors Conference, Case Western Reserve University School of Law, Cleveland, Ohio, June 2018.“(Why) Follow-On Biologics Are Set Up to Fail,” the 2018 Bio LawLaPalooza, Stanford Law School, Palo Alto, California, March 2018. “Genetic Paparazzi,” Wiet Life Science Law Scholars Conference, Loyola University Chicago School of Law, Chicago, Illinois, October 2017. “Genetic Paparazzi,” 40th Annual Health Law Professors Conference, Georgia State University College of Law, Atlanta, Georgia, June 2017.“Genetic Paparazzi,” Fifth Annual Conference on Governance of Emerging Technologies: Law, Policy and Ethics, Arizona State University, Phoenix, Arizona, May 2017.“Genetic Paparazzi,” Bio LawLaPaLooza, Stanford Law School, Palo Alto, California, April 2017. “State of Autonomous Vehicles (AVs) Legislation and Regulation in the United States,” 2016 Legislative Attorneys Continuing Legal Education (CLE), Atlanta, Georgia, November 2016. “Recalibrating Incentives for Research and Development in the Pharmaceutical Industry,” 16th Annual Intellectual Property Scholars Conference, Stanford Law School, Palo Alto, California, August 2016.“Should All Healthcare Companies Be(come) Benefit Corporations?,” 39th Annual Health Law Professors Conference, Boston University School of Law, Boston, Massachusetts, June 2016.“The Current State of Autonomous Vehicles Laws and Ways of Moving Forward,” Fourth Annual Conference on Governance of Emerging Technologies: Law, Policy and Ethics, Arizona State University, Tempe, Arizona, May 2016.“Autonomous Vehicles & Car Accident Liability,” presentation to the American Association of Motor Vehicles Administrators (AAMVA) Autonomous Vehicles Information Sharing Group (via teleconference), September 2015. “The Biologics Price Competition and Innovation Act (BPCIA): A Failed Experiment, Sham, or an Exercise in Futility,” 15th Annual Intellectual Property Scholars Conference, DePaul University College of Law, Chicago, Illinois, August 2015.“Five Years to the Biologics Price Competition and Innovation Act (BPCIA): A Stocktaking,” PatCon5, University of Kansas School of Law, Lawrence, KS, April 2015. “Five Years to the Biologics Price Competition and Innovation Act (BPCIA): A Stocktaking,” 2015 Works-in-Progress Intellectual Property Colloquium, the United States Patent and Trademark Office and George Washington University Law School, Washington DC, February 2015. SEQ CHAPTER \h \r 1“Envisioning FDA Evaluation and Approval of Pharmaceuticals for Non-Therapeutic Uses,” Emerging Issues and New Frontiers for FDA Regulation Symposium, Harvard Law School Petrie-Flom Center and the Food and Drug Law Institute, Washington DC, October 2014. “Regulatory Competitive Shelters (RCSs) As Incentives for Innovation in Agro-Biotech,” Public Domain(s): Law, Generating Knowledge, and Furthering Innovation in the Information Economy Symposium, Michigan State University College of Law, East Lansing, Michigan, October 2014. “A Legal Framework for Approval and Access to Neuro-Enhancing Chemicals,” Neuro-Interventions and the Law Conference: Regulating Human Mental Capacity, Georgia State University, Atlanta, Georgia, September 2014. “Regulatory Competitive Shelters in Personalized Medicine,” Workshop on Personalized Medicine and Intellectual Property, Boston University School of Law, Boston, Massachusetts, August 2014. “Regulatory Competitive Shelters (RCSs) as Patent Substitutes,” 14th Annual Intellectual Property Scholars Conference, University of California, Berkeley, School of Law, Berkeley, California, August 2014. “Regulatory Competitive Shelters (RCSs) as Patent Substitutes,” 37th Annual Health Law Professors Conference, University of California, Hastings College of Law, San Francisco, California, June 2014. “On Patenting ‘Human Organisms’ or How the Abortion Wars Undermine Technological Innovation,” Second Annual Conference on Governance of Emerging Technologies: Law, Policy and Ethics, Arizona State University, Phoenix, Arizona, May 2014.“Regulatory Competitive Shelters as Patent Substitutes,” PatCon 4, University of San Diego, San Diego, April 2014. “Patenting DNA, Humans, Etc.—How the Supreme Court Got It Wrong,” Regent University School of Law, Virginia Beach, February 2014. “On Patenting Human Organisms,” Personhood Beyond the Human Conference, Yale University, New Haven, Connecticut, December 2013. “Regulatory Competitive Shelters as Patent Substitutes in Pharmaceuticals,” IPublic Health: The Intersection of Intellectual Property Rights and Public Health Symposium, The John Marshall Law School, Chicago, Illinois, November 2013. “Regulatory Competitive Shelters—An Emerging Class of Administrative Properties,” (article reviewed by Prof. Emily Michiko Morris) Intellectual Property Scholars Conference, Cardozo Law School, New York City, New York, August 2013. “Regulatory Competitive Shelters—An Emerging Mechanism for Encouraging Technological Innovation,” Governance of Emerging Technologies, Arizona State University, Chandler, Arizona, May 2013. “Regulatory Competitive Shelters—An Emerging Class of Intellectual Property,” Works-in-Progress in Intellectual Property (WIPIP) Colloquium, Seton Hall University School of Law, Newark, New Jersey, February 2013. “Regulatory Competitive Immunities—An Emerging Class of Intellectual Property,” Junior Faculty Scholarship Workshop – Intellectual Property Issues in the Pharmaceutical Industry, Indiana University Robert H. McKinney School of Law, Indianapolis, Indiana, December 2012. “On Patenting Humans, Or How Abortion Politics and Technophobia Created the Distinction Between Patently Human and Patentably Non-Human,” Intellectual Property Scholars Conference, John Marshall of Atlanta School of Law, Atlanta, Georgia, August 2012. “On Patenting Humans, Or How Abortion Politics and Technophobia Created the Distinction Between Patently Human and Patentably Non-Human,” 12th Annual Intellectual Property Scholars Conference, Stanford Law School, Palo Alto, California, August 2012. “How Abortion Politics and Technophobia Created the Distinction Between Patently Human and Patentably Non-Human,” 35th Annual Health Law Professors Conference, Arizona State University, Sandra Day O’Connor College of Law, June 2012.“How Abortion Politics and Technophobia Created the Distinction Between Patently Human and Patentably Non-Human,” Emory Law School Summer Workshop, Atlanta, Georgia, June 2012.“How Abortion Politics and Technophobia Gave Us the Distinction Between Patentably Non-Human and Patently Human,” 2012 IP Scholars Roundtable, Drake University Law School, Des Moines, Iowa, March 2012. “How Abortion Politics and Technophobia Gave Us the Distinction Between Patentably Non-Human and Patently Human,” Works-in-Progress in Intellectual Property (WIPIP) Colloquium, University of Houston Law Center, Houston, Texas, February 2012. “Patents vs. Statutory Exclusivities in Biological Pharmaceuticals—Do We Really Need Both?” Intellectual Property Scholars Conference, DePaul University College of Law, Chicago, Illinois, August 2011.“Patents vs. Statutory Exclusivities in Biological Pharmaceuticals—Do We Really Need Both?” 34th Annual Health Law Professors Conference, Loyola University Chicago School of Law, Chicago, Illinois, June 2011. WORKSHOPS AND PANELS SEQ CHAPTER \h \r 1Participant, 2019 bioip Faculty Workshop, Boston University School of Law, Boston, Massachusetts, April 2019. Co-Organizer and Moderator, Solving America’s Drug Pricing Problem, Georgia State University College of Law, Atlanta, Georgia, January 2019.Participant, Eric Posner’s “American Demagogue” Book Workshop, Georgia State University College of Law, Atlanta, Georgia, December 2018. Panelist, Justice in the Brave New World: Technology and the Role of the Law in the 21st Century, Emory University School of Law, Atlanta, Georgia, October 2018. Organizer and Commentator, 2018 bioip Faculty Workshop, Georgia State University College of Law, Atlanta, Georgia, May 2018.Participant, “Follow-On Biologics Are Set Up to Fail,” Regulation and Innovation in the Biosciences (RIBS) Workshop, Washington University School of Law, St. Louis, Missouri, April 2018.Participant, “Why Follow-On Biologics Are Set Up to Fail,” Georgia IP Scholars Workshop, Emory University Law School, Atlanta, Georgia, December 2017. Participant, 2017 bioip Faculty Workshop, Loyola University Chicago School of Law, Chicago, Illinois, May 2017. Presenter (with Liza Vertinsky and Cass Brewer), “Alternative Business Forms for Companies in Healthcare Markets,” Emory Colloquium, Emory University Law School, Atlanta, Georgia, April 2017. Panelist, 2016 Intellectual Property Career Showcase, Georgia Institute of Technology, Atlanta, Georgia, October 2016. Participant, 2016 Junior Intellectual Property Scholars Association (JIPSA) Workshop, Florida International University, Miami, Florida, January 2016. Participant, 2015 bioip Faculty Workshop, Boston University School of Law, Boston, Massachusetts, May 2015. Panelist, “2020: An IP Odyssey: DNA Paparazzi,” 2014 Southeastern Association of Law Schools (SEALS) Conference, Amelia Island, Florida, August 2014. Participant, “Regulatory Competitive Shelters as Patent Substitutes,” Junior Intellectual Property Scholars Association Workshop 2014, Washburn University School of Law, Topeka, Kansas, June 2014. Panelist, “Patentable Subject Matter: What’s Patentable Today May Not Be Patentable Tomorrow,” 2013 Southeastern Association of Law Schools (SEALS) Conference, West Palm Beach, Florida, August 2013. Discussant, Intellectual Property Boot Camp, University of New Hampshire Law School, Holderness, New Hampshire, June 2013. Moderator and organizer, “Copyrighting DNA: Protecting Synthetic DNA Sequences as a Work of Authorship,” Center for Law, Health and Society, Georgia State University College of Law, January 2013. Discussant, Sixth Annual Intellectual Property Scholars Forum; topic: “The Impact of IP on Public Health,” sponsored by the University of Akron School of Law’s Center for Intellectual Property & Technology, Akron, Ohio, October 2012, (memorialized in Ryan G. Vacca, Jim Chen, Jay Dratler, Tom Folsom, Timothy Hall, Yaniv Heled, Frank Pasquale, Elizabeth Reilly, Jeff Samuels, Kathy Strandburg, Kara Swanson, Andrew Torrance, Katharine Van Tassel, Intellectual Property and Public Health – A White Paper, 7 Akron Intell. Prop. J. (2013), available at ). Panelist, “Biosimilars: Where Do We Stand?,” Georgia BIO and Georgia Association of Healthcare Executives, Atlanta, Georgia, September 2012. COMMUNITY AND UNIVERSITY PRESENTATIONS “Introduction to Intellectual Property (IP) for Creatives,” Intellectual Property Essentials for Creatives, Georgia State University College of Law & Center for Media Industries Institute, Atlanta, Georgia, November 2019. Israeli Politics, the Israeli-Palestinian Relationship, and an Israeli Perspective on Recent Developments in the Middle East, Kennesaw State University Department of Political Science and International Affairs, Politics of the Middle East (POLS 4454), Kennesaw, Georgia, October 2018. “Genetic Paparazzi: About the Genetic Privacy of Public Figures,” Privacy & Technology Law Section of the Georgia Bar, Atlanta, Georgia, September 2018.“On Intellectual Property, Access to Medicine, and the Structure of U.S. Healthcare Markets,” University of Warsaw School of Law Common Law Society, University of Warsaw School of Law, Warsaw, Poland, February 2018. Israeli Politics, the Israeli-Palestinian Relationship, and an Israeli Perspective on Recent Developments in the Middle East, Kennesaw State University Department of Political Science and International Affairs, Politics of the Middle East (POLS 4454), Kennesaw, Georgia, November 2017.“On Being Human: Scenes from District 9,” Georgia State University College of Law, Bioethics in the Movies Lecture Series, February 2017.“And Now for Something Completely Different: The Monty Python Bioethics Corpus,” Georgia State University College of Law, Bioethics in the Movies Lecture Series, February 2016. “The Technology is Nano; Legal Challenges are Enormous,” Nano@Tech Lecture Series, Georgia Institute of Technology, Atlanta, Georgia, April 2015.Israeli Politics, the Israeli-Palestinian Relationship, and an Israeli Perspective on Recent Developments in the Middle East, Kennesaw State University Department of Political Science and International Affairs, Politics of the Middle East (POLS 4454), Kennesaw, Georgia, October 2014.“Patent Law Between the Supreme Court and a Hard Place,” Eighth Annual Corporate IP Institute, Georgia State University College of Law and Robinson College of Business, Atlanta, Georgia, October 2014. SEQ CHAPTER \h \r 1Israeli Politics, the Israeli-Palestinian Relationship, and an Israeli Perspective on Recent Developments in the Middle East, Kennesaw State University Department of Political Science and International Affairs, Politics of the Middle East (POLS 4454), Kennesaw, Georgia, October 2013. “The ACLU v. Myriad Case and its Implications on Healthcare,” Georgia State University College of Law, Atlanta, Georgia, April 2013.“Recent Developments in Patent Law,” Ninth Annual Hot Topics in IP, Georgia State University College of Law, Atlanta, Georgia, May 2013. “Subject Matter Eligibility Under 35 U.S.C § 101 as a Defense to Patent Infringement,” (moderator and panelist) Ninth Annual SpringPosium, Atlanta Bar and Georgia State University, Barnsley Gardens, Georgia, April 2013.“Changes to Patentable Subject Matter Law Under the America Invents Act,” (panelist), America Invents Act Update, Georgia State University College of Law, Atlanta, Georgia, April 2013.Israeli Politics and the Israeli-Palestinian Relationship, Kennesaw State University Department of Political Science and International Affairs, Politics of the Middle East (POLS 4454), Kennesaw, Georgia, March 2013. “A Comparative Introduction to the Israeli Legal System and Legal Practice in Israel,” Georgia State University College of Law, International & Foreign Legal Research (LAW7288), March 2013. “Bioethics Paradigm Shift in a Post-Zombie-Apocalypse World: Scenes from ‘The Walking Dead,’” Georgia State University College of Law, Bioethics in the Movies Lecture Series, March 2013. “Developments in the Law of Patentable Subject Matter Relevant to the Biotechnology Industry,” (panelist) Statutory Subject Matter, Eighth Annual SpringPosium, Barnsley Gardens, Georgia, April 2012.“A Comparative Introduction to the Israeli Legal System and Legal Practice in Israel,” Georgia State University College of Law, International & Foreign Legal Research (LAW7288), March 2012.“The Monty Python Bioethics Corpus,” Georgia State University College of Law, Bioethics in the Movies Lecture Series, February 2012. ONLINE MEDIA APPEARANCESLawsuit: Drug company ups drug price from $40 to $39,000, 11 Alive (WXIA) (February 17, 2020), . Professor Yaniv Heled Answers All Your Patent Related Questions, Considering Apple (September 14, 2012), HONORS AND AWARDS2004Harlan Fiske Stone Scholar, Columbia University School of Law2000Magna Cum Laude, Tel Aviv University Faculty of Life SciencesPROFESSIONAL AFFILIATIONS & LICENSES2015 – presentCo-Director, Center for Intellectual Property, Georgia State University College of Law2011 – presentMember, Center for Law, Health & Society, Georgia State University College of Law2013 – 2016Member, Atlanta IP Inn of Court2009 Federal Court for the Southern District of New York2003New York State Bar (License No. 4151221)2002Israel Bar (License no. 33084)PUBLIC AND PROFESSIONAL SERVICE2020Drafter, Brief of Amici Curiae Law Professors of Tort Law, Family Law and Health Law in Support of Plaintiff-Appellants, Wendy Norman et al. v. Xytex Corp. et al., No. S19G1486 (Ga. Feb. 26, 2020)2019Signatory, Brief Amici Curiae of 82 Law, Economics, Business, and Medical Professors in Support of Respondent, Impax Labs., Inc. v. Federal Trade Commission (on Petition for Review from the Federal Trade Commission, No. 9373), No. 19-60394 (5th Cir. Dec. 16, 2019)2019Signatory, Brief of Biomedical Ethicists Ruth R. Faden, Ph.D., M.P.H., et al. as Amici Curiae in Support of Petitioners, EMW Women’s Surgical Center, P.S.C., et al. v. Adam Meier (on Petition for a Writ of Certiorari to the United States Court of Appeals for the Sixth Circuit), No. 19-417 (Oct. 28, 2019; denied)2019Drafter, Brief of Amici Curiae Law Professors of Tort Law, Family Law and Health Law in Support of Plaintiff-Petitioners’ Petition for Certiorari, Wendy Norman et al. v. Xytex Corp. et al., No. S19C1486 (Ga. Jul. 29, 2019)2019Peer reviewer, Journal of Legal Medicine2019Peer reviewer, Journal of Science & Engineering Ethics2019Drafter, Brief of Amici Curiae Health Law and Family Law Professors in Support of Plaintiffs, Jennifer Cruz et al. v. Xytex Corp. et al., No. 2018CV307445 (Ga. Superior Ct. Feb. 20, 2019).2019Drafter, Brief of Amici Curiae Health Law and Family Law Professors in Support of Plaintiff-Appellants, Wendy Norman et al. v. Xytex Corp. et al., No. A19A0445 (Ga. Ct. App. Feb. 15, 2019). 2018Drafter, Legal Scholars’ Letter to the Food and Drug Administration Regarding FDA’s Approach to Facilitating Competition and Innovation in the Biological Products Marketplace, Docket No. FDA–2018-N-2689 (Sep. 21, 2018)2018Signatory, Brief of Amici Curiae 45 Intellectual Property Professors in Support of Appellant, Helsinn Healthcare S.A. v Teva Pharmaceuticals USA, Inc., on Write of Certiorari to the United States Court of Appeals for the Federal Circuit, No. 17-1229 (Oct. 2018).2018Signatory, Brief of Amici Curiae Intellectual Property Law Professors in Support of Petitioner, Ariosa Diagnostics, Inc. v. Illumina, Inc., on Petition for Writ of Certiorari to the United States Court of Appeals for the Federal Circuit, No. 18-109 (Aug. 2018).2018Signatory, Brief Amici Curiae of Intellectual Property Professors in Support of Appellees, Regents of the University of Minnesota v. LSI Corp., Nos. 2018-1559, -1560, -1561, -1562, -1563, -1564, -1565 (Fed. Cir. Aug. 2018).2018Referee, grant proposal to the Marsden Fund of the Royal Society Te Apārangi of New Zealand (July 2018).2017Signatory, Brief of Intellectual Property Law Professors as Amici Curiae in Support of Petition for Rehearing En Banc, Ariosa Diagnostics, Inc., v. Illumina, Inc., Nos. 2016-2388, 2017-1020 (Fed. Cir. Feb. 2018).2017Signatory, Brief for 72 Professors of Intellectual Property Law as Amici Curiae in Support of Respondents, on Write of Certiorari to the U.S. Court of Appeals for the Federal Circuit, Oil States Energy Services, LLC, v. Greene’s Energy Group, LLC, No. 16-712 (Oct. 2017).2017Signatory, Brief Amici Curiae of 58 Law, Economics, and Business Professors in Support of Appellants’ Petition for Panel Rehearing or Rehearing En Banc, In re Wellbutrin XL Antitrust Litigation, Nos. 15-2875/3559/3591/3681/3682 (3rd Cir. Sept. 7, 2017).2017Signatory, Brief of 44 Election Law, Scientific Evidence, and Empirical Legal Scholars as Amici Curiae in Support of Appellees, in the Supreme Court of the United States, on Appeal from the District Court for the Western District of Wisconsin, Beverly R. Gill, et al. v. William Whitford, et al., No. 16-1161 (Sept. 1, 2017).2017Signatory, “We Stand for Access,” Letter from 130 Professors of Health Law, Medicine, and Bioethics, (June 2017).2017Signatory, 230 Law and Economics Professors’ Letter to President Trump to Remove Investor-State Dispute Settlement (ISDS) From NAFTA and Other Pacts (Oct. 25, 2017).2016Signatory, Brief of Amici Curiae 61 Professors of Law and Economics in Support of Petition for Writ of Certiorari, TC Heartland LLC v. Kraft Foods Group Brands LLC, No. 16-341 (Oct. 17, 2016; granted).2016Signatory, Professors’ Letter to Deputy Solicitor General of the United States, Malcolm Stewart, recommending against a grant of certiorari by the Supreme Court in SmithKline Beecham Corp. et al. v. King Drug of Florence, Inc. et al., No. 15-1055 (cert. petition denied, Nov. 7, 2016). 2016Signatory, Professors’ Letter to Congress Supporting Venue Reform (July 12, 2016). 2015Signatory, Brief Amici Curiae of 48 Law, Economics, and Business Professors and the American Antitrust Institute in Support of Appeallants, In re Lipitor Antitrust Litigation, Nos. 14-4202, 14-4203, 14-4204, 14-4205, 14-4206, 14-6202, and 14-4632 (3rd Cir. Dec. 28, 2015; reversed). 2015Signatory, Brief Amici Curiae of 48 Law, Economics, and Business Professors and the American Antitrust Institute in Support of Appeallants, In re Effexor XR Antitrust Litigation, Nos. 15-1184, 15-1185, 15-1186, 15-1187, 15-1274, 15-1323, and 15-1342 (3rd Cir. Nov. 17, 2015; reversed). 2015Signatory, Law Professors’ Letter to Congress in Support of the SPEAK FREE Act of 2015 (Sep. 16, 2015). 2015Signatory, Brief of Twenty-Three Law Professors in Support of Appellant’s Petition for Rehearing En Banc, Ariosa Diagnostics v. Sequenom, Nos. 2014-1139 and 2014-1144 (Fed. Cir. Aug. 27, 2015). 2015Signatory, Brief Amici Curiae on Behalf of 70 Law, Economics, and Business Professors and the American Antitrust Institute in Support of Appellants, In re: Loestrin 24 FE Antitrust Litigation, Nos. 14-2071, 15-1250 (1st Cir. June 16, 2015). 2015Peer reviewer, Yale Journal of Health Policy, Law, and Ethics. 2015Peer reviewer, Jurimetrics: The Journal of Law, Science, and Technology. 2014 – presentFounder and Member of Organizing Committee, bioip Workshop (a rotating annual national workshop dedicated to the intersection of intellectual property and the biomedical sciences established in collaboration with Boston University School of Law, Loyola University Chicago School of Law, and Indiana University McKinney School of Law)2014Peer reviewer, Journal of Philosophy, Science & Law. 2013Signatory, Law Professors’ Letter to Congress in Support of Patent Reform Legislation (Nov. 25, 2013). 2013Peer reviewer, Stanford Journal of Law, Science & Policy. 2013 – 2016 Member, Board of Directors, Intellectual Property Section, Atlanta BarUNIVERSITY SERVICE 2019 – presentMember, College of Law Recruitment Committee2019 – present Member, College of Law LL.M. Committee2018 – 2019Member, College of Law Curriculum Committee2017 – 2018Member, College of Law Non-JD (Domestic) Committee2011 – present Member, Executive Committee, Intellectual Property Advisory Board (IPAB), Georgia State University College of Law2016 – 2017 Member, College of Law Dean’s Advisory Committee2014 – 2017 Member, University Entrepreneurship & Innovation Working Group2013 – 2014Member, Awards Committee, Georgia State University College of Law2013 – 2016Member, LL.M. Program Advisory Group, Georgia State University College of Law2012 – 2016 Member, Speakers Committee, Georgia State University College of Law2012 – 2013;2014 – 2015Member, Scholarships Committee, Georgia State University College of LawTEACHINGCourses2018 – presentBiotechnology Law, Policy & Ethics2016 – present Family Law2012 – presentPatent LawSpring 2018Introduction to American Intellectual Property Law, University of Warsaw School of Law, Warsaw, Poland2011 – 2013; 2015 – 2017 Intellectual Property Survey, Georgia State University College of Law2016Different & Unusual Forms of Intellectual Property, Georgia State University College of Law2012 – 2015Law & Emerging Technologies, Georgia State University College of Law (updated Mar. 1, 2020) ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download